The pharmaceutical firm making cystic fibrosis drug – Orkambi- says it’s got EU approval to treat children.
Manufacturer Vertex says it’ll now be suitable for use for those aged 6 to 11.
It’s already licensed for patients 12 and over.
Earlier this year the HSE agreed to make Orkambi available to Irish patients after major price negotiations with the pharma industry.
Advertisement